Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Non-small Cell Lung Cancer × Carboplatin × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 162 Ovarian Neoplasms 56 Lung Neoplasms 55 Breast Neoplasms 30 Fallopian Tube Neoplasms 29 Small Cell Lung Carcinoma 28 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Carcinoma, Ovarian Epithelial 22 Uterine Cervical Neoplasms 18 Triple Negative Breast Neoplasms 18 Neuroblastoma 16 Carcinoma 15 Squamous Cell Carcinoma of Head and Neck 14 Neoplasm Metastasis 12 Endometrial Neoplasms 12 Adenocarcinoma of Lung 11 Neoplasms 10 Head and Neck Neoplasms 9 Recurrence 8 Peritoneal Neoplasms 7 Central Nervous System Neoplasms 7 Carcinoma, Transitional Cell 7 Brenner Tumor 7 Esophageal Neoplasms 6 Urinary Bladder Neoplasms 5 Testicular Neoplasms 5 Lung Diseases 5 Hepatoblastoma 5 Thoracic Neoplasms 4 Teratoma 4

Interventions

pembrolizumab 1 aumolertinib 1 anlotinib 1 abivertinib 1 Radiosurgery 1 Pemetrexed 1 Gefitinib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06452277 2026-03-02

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡